Back to top
more

Inventiva (IVA)

(Delayed Data from NSDQ)

$2.68 USD

2.68
21,464

-0.05 (-1.65%)

Updated Jul 12, 2024 03:43 PM ET

After-Market: $2.73 +0.05 (1.87%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (75 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for IVA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Inventiva SA Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 29 91 102 121 40
Receivables 10 6 10 10 11
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 13 14 24 20 3
Total Current Assets 52 112 137 152 55
Net Property & Equipment 10 8 4 4 4
Investments & Advances 2 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 1 1 1 1 1
Deposits & Other Assets 11 2 3 2 4
Total Assets 75 122 144 159 64
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 41 20 17 8 8
Current Portion Long-Term Debt 6 6 2 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 8 6 8 8 7
Total Current Liabilities 54 32 27 16 16
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 35 30 10 11 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 21 12 2 4 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 110 74 39 32 17
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 0 0 0 0
Capital Surplus 218 183 195 160 96
Retained Earnings -120 -57 -59 -38 -34
Other Equity -134 -79 -32 5 -16
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -35 48 105 127 46
Total Liabilities & Shareholder's Equity 75 122 144 159 64
Total Common Equity -35 48 105 127 46
Shares Outstanding 52.10 42.10 40.70 38.30 NA
Book Value Per Share -0.67 1.14 2.58 3.32 0.00

Fiscal Year End for Inventiva SA Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 -99,999 29 -99,999 -99,965
Receivables NA NA 10 NA 7
Notes Receivable NA NA 0 NA NA
Inventories NA NA 0 NA 0
Other Current Assets NA NA 13 NA 15
Total Current Assets NA NA 52 NA 57
Net Property & Equipment NA NA 10 NA 8
Investments & Advances NA NA 2 NA NA
Other Non-Current Assets NA NA 0 NA NA
Deferred Charges NA NA 0 NA NA
Intangibles NA NA 1 NA 1
Deposits & Other Assets NA NA 11 NA 11
Total Assets NA NA 75 NA 77
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA NA 0 NA NA
Accounts Payable NA NA 41 NA 31
Current Portion Long-Term Debt NA NA 6 NA 4
Current Portion Capital Leases NA NA 0 NA NA
Accrued Expenses NA NA 0 NA NA
Income Taxes Payable NA NA 0 NA NA
Other Current Liabilities NA NA 8 NA 5
Total Current Liabilities NA NA 54 NA 41
Mortgages NA NA 0 NA NA
Deferred Taxes/Income NA NA 0 NA NA
Convertible Debt NA NA 0 NA NA
Long-Term Debt NA NA 35 NA 34
Non-Current Capital Leases NA NA 0 NA NA
Other Non-Current Liabilities NA 21 NA 11
Minority Interest (Liabilities) NA NA 0 NA NA
Total Liabilities NA NA 110 NA 86
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA NA 0 NA NA
Common Stock (Par) NA NA 1 NA 0
Capital Surplus NA NA 218 NA 190
Retained Earnings NA NA -120 NA -60
Other Equity NA NA -134 NA -138
Treasury Stock NA NA 0 NA NA
Total Shareholder's Equity NA NA -35 NA -8
Total Liabilities & Shareholder's Equity NA NA 75 NA 77
Total Common Equity 0 0 -35 0 99,991
Shares Outstanding 52.40 52.10 52.10 51.70 42.10
Book Value Per Share 0.00 0.00 -0.67 0.00 2,375.07